AbbVie | ABBV - Assets

Stock Price
198.71
Daily Change
-2.24 -1.11%
Monthly
-4.09%
Yearly
6.80%
Q2 Forecast
194.46

AbbVie reported $133.96B in Assets for its fiscal quarter ending in December of 2025.





Assets Change Date
AbbVie USD 133.96B 62M Dec/2025
Abbott USD 86.71B 2.53B Dec/2025
ALKERMES USD 2.49B 157.48M Dec/2025
Amgen USD 90.59B 445M Dec/2025
AstraZeneca USD 114.07B 382M Dec/2025
Biogen USD 29.44B 232M Dec/2025
BioMarin Pharmaceutical USD 7.59B 20.85M Dec/2025
Bristol-Myers Squibb USD 96.89B 2.21B Sep/2025
Coherus Biosciences USD 258.34M 258.18M Dec/2025
Eisai JPY 1.49T 48.22B Dec/2025
Eli Lilly USD 112.48B 2.46B Dec/2025
Gilead Sciences USD 59.02B 490M Dec/2025
GlaxoSmithKline GBP 61.12B 221M Dec/2025
Infinity Pharmaceuticals USD 21.23M 8.72M Jun/2023
J&J USD 200.89B 1.68B Mar/2026
Medtronic USD 91.48B 139M Dec/2025
Merck USD 129.55B 12.02B Sep/2025
Neurocrine Biosciences USD 4.63B 365.8M Dec/2025
Novartis USD 110.95B 3.66B Dec/2025
Pacira USD 1.26B 32.66M Dec/2025
Perrigo USD 8.54B 1.55B Dec/2025
Pfizer USD 208.73B 2.64B Sep/2025
Regeneron Pharmaceuticals USD 40.56B 389.3M Dec/2025
Roche Holding CHF 100.7B 5.94B Dec/2025
Sanofi EUR 128.02B 1.22B Mar/2026
UCB EUR 18.16B 971M Dec/2025
Ultragenyx Pharmaceutical USD 1.53B 341.56M Dec/2025
United Therapeutics USD 7.88B 528.9M Dec/2025
Vertex Pharmaceuticals USD 25.64B 780.7M Dec/2025
Zoetis USD 15.47B 308M Dec/2025